SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-026719
Filing Date
2019-05-16
Accepted
2019-05-16 09:44:28
Documents
16
Period of Report
2019-06-28
Effectiveness Date
2019-05-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv521669-def14a.htm DEF 14A 1143449
2 GRAPHIC lg_novavax-today.jpg GRAPHIC 65313
3 GRAPHIC sg_stanley-erck.jpg GRAPHIC 28262
4 GRAPHIC lg_novavax.jpg GRAPHIC 46623
5 GRAPHIC sg_john-herrmann3.jpg GRAPHIC 16090
6 GRAPHIC ph_rachelk-king.jpg GRAPHIC 7642
7 GRAPHIC ph_michaela-mcmanus.jpg GRAPHIC 40361
8 GRAPHIC ph_jamesf-young.jpg GRAPHIC 39849
9 GRAPHIC ph_stanleyc-erck.jpg GRAPHIC 38419
10 GRAPHIC ph_rajivi-modi.jpg GRAPHIC 48093
11 GRAPHIC ph_richardh-douglas.jpg GRAPHIC 42296
12 GRAPHIC ph_garyc-evans.jpg GRAPHIC 45842
13 GRAPHIC tv521669_prycrd1.jpg GRAPHIC 681389
14 GRAPHIC tv521669_prycrd2.jpg GRAPHIC 553102
15 GRAPHIC tv521669_prycrd3.jpg GRAPHIC 807150
16 GRAPHIC tv521669_prycrd4.jpg GRAPHIC 461416
  Complete submission text file 0001144204-19-026719.txt   5170408
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 19830724
SIC: 2836 Biological Products, (No Diagnostic Substances)